Navigation Links
Hospira Names John B. Elliot Senior Vice President of Operations

LAKE FOREST, Ill., April 11, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that John B. Elliot has been named senior vice president, Operations, effective April 16. In this role, Mr. Elliot will have overall responsibility for Hospira's global operations organization and serve as a member of Hospira's senior leadership team. He will report directly to F. Michael Ball, chief executive officer.

"John is a seasoned global leader with more than 35 years of broad manufacturing experience across production, logistics and supply, and specific expertise in injectable pharmaceuticals," said Mr. Ball. "With his proven track record in driving improvements in quality, service and operational effectiveness, we're confident John will have an immediate, positive impact as we continue our efforts to deliver high-quality, cost-effective products to customers and ultimately establish our manufacturing operations as a strategic, competitive advantage."

Mr. Elliot, 60, has most recently advised some of the world's largest pharmaceutical companies in his role as an operations consultant. He previously served as president and chairman at Cherokee Pharmaceuticals, LLC (subsequently acquired by Merck & Co.), a U.S.-based active ingredients manufacturing company, where he led the organization from start-up to become a significant competitor in the contract manufacturing marketplace. Prior to Cherokee, Mr. Elliot spent 26 years with GlaxoSmithKline plc (formerly SmithKline Beecham), most recently serving as senior vice president. During his tenure, he held various roles of progressive responsibility in the operations organization and was credited for inculcating a high-performance culture across his plant network.

Under Mr. Elliot's leadership, Hospira will advance its plant remediation strategies and create additional manufacturing capacity, including the construction of a new 1.1 million square-foot, state-of-the-art facility in India. Mr. Elliot joins an operations leadership team that has recently been strengthened by the addition of top industry talent, including the appointment of Zena G. Kaufman as Hospira's new senior vice president of Quality in February.

Born and educated in Scotland, Mr. Elliot earned his bachelor's degree, with honors, in chemical engineering from Heriot-Watt University in Edinburgh.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
2. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
3. Hospira Receives Favorable Court Decision on Eloxatin(R)
4. Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) Technologies
5. Hospira Names Brian Meadows Supply Chain Chief
6. Hospira Supports Newly Introduced Biogenerics Legislation
7. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
8. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
9. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
10. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
11. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
Post Your Comments:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
Breaking Biology News(10 mins):